Stop guessing what FDA wants — walk into your Q-Sub meeting with a framework that gets answers. Six documents covering request letters, meeting prep, question framing, and follow-through.
Instant download. For regulatory affairs teams at FDA-regulated device companies.
FDA's Pre-Submission program is the single most valuable regulatory tool available to device manufacturers. But most companies waste it. They submit vague questions, disorganized background packages, and walk out with generic feedback they could have found in a guidance document.
This toolkit gives you the request letter, the meeting agenda, the background package structure, the question framework, and the response tracking system — everything needed to make your Q-Sub meeting actually productive.
From initial request through post-meeting follow-up and submission alignment.
Complete pre-submission request letter aligned to FDA eSTAR format requirements. Covers device description, regulatory pathway rationale, submission type classification, and meeting request justification. Includes all required fields and formatting guidance per FDA Pre-Submission Program guidance document.
Structured agenda framework for FDA pre-submission meetings. Covers introductions, device overview, regulatory strategy discussion, specific questions walkthrough, and next steps. Timed sections based on FDA's standard 60-minute meeting format with guidance on what FDA reviewers expect at each stage.
Complete framework for assembling the background package FDA reviewers need before your meeting. Covers device description, intended use, predicate comparison, testing strategy, clinical evidence plan, and regulatory pathway rationale. Structured to give reviewers exactly what they need to provide substantive feedback.
Structured question framework with guidance on how to frame questions FDA will actually answer. Covers the difference between questions that get actionable feedback vs. questions FDA deflects. Includes question categories: testing strategy, clinical requirements, predicate selection, labeling, and submission format.
Tracking system for documenting FDA's responses, action items, and commitments from your pre-submission meeting. Maps each question to FDA's response, identifies areas of agreement, flags unresolved issues, and tracks follow-up commitments. Critical for demonstrating consistency in your eventual submission.
Post-meeting action tracking framework covering internal tasks, FDA follow-up items, testing protocol modifications, submission timeline updates, and stakeholder communications. Includes ownership assignment, deadline tracking, and dependency mapping to keep your submission on track after the Q-Sub meeting.
The #1 mistake in Q-Sub meetings: asking vague questions FDA can only respond to with "it depends." The Questions List Template shows you how to frame specific, actionable questions that get concrete guidance.
FDA reviewers prep from your background package. A disorganized package means a disorganized meeting. The Structure Guide ensures reviewers walk in ready to give you substantive, specific feedback.
What FDA says in a pre-sub meeting shapes your entire submission strategy. The Response Tracking Log and Action Items Template ensure nothing falls through the cracks between meeting and submission.
“I built these templates from years of navigating FDA pre-submission meetings for Class II and III devices. Every document reflects what FDA reviewers actually respond to — not what consultants guess they want. We use these exact frameworks at AB Medical.”
Joshua Millage, CEO — AB Medical Technologies
“The difference between a productive Q-Sub meeting and a wasted one comes down to preparation. These templates ensure you walk in with the right questions framed the right way. We developed them alongside our own regulatory submissions.”
Rick, Director of Engineering & Regulatory — AB Medical Technologies
A Pre-Submission (Q-Sub) is a formal FDA feedback mechanism where device manufacturers can get FDA's input on specific questions before submitting a 510(k), De Novo, PMA, or IDE. It's your chance to align with FDA on testing strategy, clinical requirements, and regulatory pathway before investing months in a submission they might reject.
Request a Q-Sub when you have unanswered questions about your regulatory strategy that could significantly impact your submission timeline or cost. Common triggers: uncertain predicate selection, unclear testing requirements, novel technology without clear guidance, or clinical study design questions. The earlier the better — ideally 6-12 months before planned submission.
FDA responds best to specific, binary or bounded questions tied to your specific device and data. Instead of "What testing do you recommend?" ask "We propose bench testing per IEC 60601-1 with the following protocol — does FDA agree this is sufficient, or are additional tests needed?" The Questions List Template covers this in detail.
No. This is a practitioner reference toolkit. Consult your regulatory counsel for formal compliance opinions.
FDA guidance, warning letters, and compliance intel — delivered daily by RegWatch Daily.
Six documents. Instant download. Complete pre-submission preparation framework.
Also: CAPA Toolkit $247 · Full Suite $449